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Increased hippocampal excitability 
in miR‑324‑null mice
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Yao Hao1,3, Colin G. Miles4, Dimitra Tsompani1, Robert M. Jackson1, Michael D. Briggs1, 
Katarzyna A. Piróg1, Ian M. Clark5, Matt J. Barter1, Gavin J. Clowry1, Fiona E. N. LeBeau1 & 
David A. Young1*
MicroRNAs are non‑coding RNAs that act to downregulate the expression of target genes by 
translational repression and degradation of messenger RNA molecules. Individual microRNAs have 
the ability to specifically target a wide array of gene transcripts, therefore allowing each microRNA to 
play key roles in multiple biological pathways. miR‑324 is a microRNA predicted to target thousands of 
RNA transcripts and is expressed far more highly in the brain than in any other tissue, suggesting that 
it may play a role in one or multiple neurological pathways. Here we present data from the first global 
miR‑324‑null mice, in which increased excitability and interictal discharges were identified in vitro in 
the hippocampus. RNA sequencing was used to identify differentially expressed genes in miR‑324‑null 
mice which may contribute to this increased hippocampal excitability, and 3′UTR luciferase assays 
and western blotting revealed that two of these, Suox and Cd300lf, are novel direct targets of miR‑
324. Characterisation of microRNAs that produce an effect on neurological activity, such as miR‑324, 
and identification of the pathways they regulate will allow a better understanding of the processes 
involved in normal neurological function and in turn may present novel pharmaceutical targets in 
treating neurological disease.
MicroRNAs (miRNAs) are a class of single-stranded non-coding RNAs (ncRNAs) that modulate the expression 
of other RNA molecules. This regulation is achieved through utilising sequences within the 3′ untranslated region 
(3′UTR) of target RNAs which are complementary to the mature miRNA sequence in order to interact and con-
sequently downregulate the translation of the  target1–3. miRNAs have been predicted to affect the expression of 
vast numbers of transcripts throughout the  genome4,5 via decapping and deadenylation of the target  transcript6–8. 
Furthermore, the mechanism of gene regulation through miRNA activity is highly conserved across the plant and 
animal  kingdoms9–11, underpinning the importance of these small ncRNAs. As such, it is unsurprising that miR-
NAs have been found to play major roles in many biological networks implicated in development and  disease12–17.
miRNAs are crucial components in normal brain development and neurological function and a complete lack 
of miRNAs results in severe consequences. Dicer1 encodes an essential endoribonuclease for miRNA processing 
and conditional Dicer1 knockout models (KO) in individual neuronal populations present with severe neurologi-
cal  abnormalities18–21. These are most commonly due to upregulation of apoptotic pathways or downregulation 
of cell proliferation, resulting in reduced brain size. The impact of some individual miRNAs on brain develop-
ment are so great that KO of the gene encoding only that miRNA can severely impact neurological functioning. 
For example, mice lacking miR-9, one of the most highly expressed miRNAs in vertebrate brains, present with 
severely abnormal telencephalic structures due to a lack of miR-9-mediated regulation of neural progenitor cell 
 proliferation22–24. Double KO of genes encoding the miR-34b/c and miR-449 clusters, which are functionally 
redundant to one  another25, mirrors Dicer1 KO models in that apoptosis is upregulated, resulting in a reduc-
tion in basal forebrain  size26. A related miRNA, miR-34a, is also important in normal brain function, and has 
been observed to produce an opposing effect to miR-34b/c in that it promotes apoptotic pathways when it is 
upregulated. Furthermore, miR-34a may contribute to the neuronal death that occurs in rodent models follow-
ing seizures, as it has been shown to be upregulated following these  events27,28. Individual miRNAs are therefore 
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essential for normal brain development and in general these key neurological miRNAs exert their effects through 
shifting the balance between neurogenesis and apoptosis.
miR-324 has previously been suggested to function in the regulation of normal neural  activity29,30 and is 
expressed more abundantly in the brain than in other  tissues31. Experimentally validated target information 
for miR-324 is somewhat limited, but the two mature miR-324 arms, miR-324-5p and -3p, are each predicted 
to target and repress a large number of genes. Amongst the targets relevant for neurological activity, App, the 
gene encoding the amyloid precursor  protein32, is one of the most confidently  predicted4,33, potentially linking 
miR-324-5p to Alzheimer’s  Disease34. miR-324-5p has also been investigated in relation to epilepsy; in a murine 
model of epilepsy, whereby wild-type (WT) mice were injected with pilocarpine in order to evoke seizure activ-
ity, the use of a miR-324-5p antagomir was found to reduce the incidence of epileptic  events30, purportedly by 
downregulating the expression of Kcnd2, a gene encoding the potassium channel protein Kv4.229,30. Deletion or 
mutation of Kcnd2 has been shown to severely impair A-type  K+  currents35–37. A detailed investigation into the 
cause of the association between miR-324 and epilepsy has however not yet been reported.
Our group has produced the first global miR-324-null mice, allowing high-throughput RNA sequencing 
(RNA-seq) to be applied in vivo for the first time to elucidate genes and pathways altered by a lack of Mir324, the 
gene encoding miR-324. Here, hippocampal slices from miR-324-null mice were found to display hyperexcit-
ability in vitro, contrasting with what has previously been  reported30. RNA-seq of hippocampus and neocortex 
identified genes that may be responsible for this phenotype and 3′UTR-luciferase assays were used to confirm 
direct interactions between miR-324 and putative targets identified using RNA-seq. Western blotting confirmed 
two of these putative targets, SUOX and CD300lf, were increased in miR-324-null hippocampal extracts. These 
interactions reveal novel regulatory activity of miR-324 on epilepsy-associated genes, allowing a better under-
standing of the processes involved in normal neurological function.
Results
Generation of miR‑324 global knockout mice. Since miR-324-5p is expressed more abundantly in 
the brain than in any other  tissue31, we initially sought to determine the functional role of the microRNA using 
a knock-out mouse model. In order to assess the activity of miR-324-5p and -3p in mice, our group produced 
the first global knockout mouse model of miR-324 (Fig. 1a,b). The expression levels of Mir324 in male 13.5 
month old WT miR-324-null mice were measured using real-time reverse transcriptase polymerase chain reac-
tion (qRT-PCR) in hippocampus and neocortex, confirming that miR-324-null mice completely lack expression 
of Mir324 (Fig. 1c). Additionally, in situ hybridisation revealed that miR-324-5p is expressed across the murine 
hippocampus in WT mice, including the CA3 region (Fig. 1d). miR-324-null mice were born at the normal Men-
delian ratio, were phenotypically normal with no obvious overt phenotype and survived with normal longevity.
miR‑324‑null mice display electrophysiological abnormalities in the hippocampus. In order 
to determine whether global miR-324-null mice exhibited any deficits in the generation of network activity, the 
local field potential (LFP) was recorded from the CA3 stratum radiatum in hippocampal slices obtained from 19 
to 21 week old female miR-324-null and WT mice (16 slices obtained from 6 mice, for each genotype). Kainate 
(KA) was used to evoke gamma-frequency oscillatory activity (20–80 Hz) at a range of concentrations between 
50 nM and 1 µM. At 0 nM KA, no spontaneous gamma-frequency oscillation was observed. As the KA con-
centration was increased, the power of the gamma-frequency oscillation increased in amplitude and area until 
400–600 nM KA, at which point the oscillation collapsed as previously  reported38. Hippocampal KA-evoked 
oscillatory activity was recorded at each concentration for 30 min and the final minute of each trace was used 
to measure area power, peak amplitude and peak frequency. All slices, both WT and miR-324-null, showed 
gamma-frequency oscillatory activity during the course of the experiment, but if no such activity was observed 
in a slice at a particular KA concentration then that slice was omitted from analysis at that concentration. Over 
the range of KA concentrations, no statistically significant differences were observed between genotypes for any 
of the metrics (Fig. 2), although area power showed a trend to be larger in the miR-324-null slices and was close 
to the significance threshold (p value = 0.068; N = 16 slices obtained from 6 mice per genotype, Supplementary 
Table S1). All three metrics were statistically significantly affected by the concentration of KA, independent of 
genotype (p values for area power, peak amplitude and peak frequency = 2.4 ×  10–25, 1.8 ×  10–20 and 1.0 ×  10–20, 
respectively). With regard to peak frequency, a shift to a higher frequency is seen between 400 and 600 nM KA 
in miR-324-null slices, whereas in WT slices this shift is less consistent.
Interestingly, in some hippocampal slices, particularly those obtained from miR-324-null mice, regular inter-
ictal discharges (IIDs) were evident following application of KA. In other slices, oscillations exhibited large so-
called ‘spikes’ in the field potential recordings. Upon comparing the proportions of all slices exhibiting IIDs in 
miR-324-null and WT slices across the range of KA concentrations used, there was a noticeable increase in the 
number of slices showing IIDs in miR-324-null slices relative to WT slices, which was most apparent at 150 and 
200 nM KA (Fig. 3). All IIDs observed in WT slices were obtained from a single mouse, whereas slices taken from 
4 of the 6 miR-324-null mice produced IIDs after KA application. The number of detected spikes and IIDs per 
minute were both significantly increased in miR-324-null mice relative to WT control (p values = 2.8 ×  10–3 and 
0.021, respectively; N = 16 slices obtained from 6 mice per genotype), demonstrating that lack of Mir324 increases 
the overall incidence of these hyperexcitable epilepsy-related events (Fig. 4). In particular, the frequency of spikes 
is significantly increased in miR-324-null slices between 150 and 800 nM of KA and the frequency of IIDs is 
significantly increased in miR-324-null slices between 150 and 400 nM of KA (p values ≤ 0.05, using Tukey’s HSD 
post-hoc tests). KA concentration was not found to significantly affect these metrics, independent of genotype.
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Figure 1.  Mir324 was knocked out in a C57/BL6 background in a 133 bp deletion. (a) The Mir324 locus and 
surrounding region in relation to the knockout. The positions from which the mature miR-324-5p and -3p arms 
are encoded are indicated and text in italics shows the locations of the protospacer-adjacent motifs used for 
the knockout. (b) Routine breeding and genotyping by PCR was used to maintain the stock, and allowed easy 
identification of whether each individual was heterozygous (HET), wild-type (WT) or miR-324-null (KO) with 
respect to Mir324. (c) The expression levels of Mir324 in hippocampus and neocortex tissue illustrate the lack 
of Mir324 in 13.5 month old male miR-324-null (KO) mice relative to WT mice. U6 was used as the control to 
normalise Mir324 levels between samples. Here, *** signifies p value ≤ 0.001, where significance was calculated 
using two-sided Student’s t-tests. (d) miR-324-5p is shown to be expressed in the murine hippocampal CA3 
region by in situ hybridisation. Arrows indicate the cells in which miR-324-5p expression is detected as 
punctate red spots. Hippocampal slices stained for negative and positive controls (a scrambled probe and U6, 
respectively) are also shown.
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Figure 2.  No change in gamma-frequency oscillations was observed between hippocampal slices  taken from 5 
month old female miR-324-null and WT mice (N = 16 slices obtained from 6 mice per genotype). (a) Example 1 
s traces of LFP recorded from a single WT and miR-324-null slice in the absence of KA (baseline) and following 
bath application of KA at 150 nM and 800 nM. In both genotypes, no spontaneous oscillations were seen 
before KA application, but clear gamma-frequency activity was evident at 150 nM. In the miR-324-null slices, 
“spikes” in the LFP are indicated by *. Oscillations subsequently collapsed at higher KA concentrations (800 
nM KA). (b–d) Comparisons between genotypes of area power, peak amplitude and peak frequency showed 
no significant differences, although area power was close to the 5% significance threshold (p value = 0.068). KA 
concentration significantly affected all three metrics. Slices that did not show clear gamma-frequency oscillatory 
activity at a particular concentration were omitted from analysis at that concentration, and therefore for some 
KA concentrations N < 16. p Values were calculated using 2-way mixed ANOVAs, although for peak amplitude 
and area power, the data was first  log10 transformed as the initial data were not normally distributed.
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Hippocampal and neocortical RNA sequencing of miR‑324‑null mice. Both miR-324-5p and miR-
324-3p are each predicted to target and repress a large number of genes; for both human and mouse, the miRNA 
target prediction algorithm  TargetScan4,33 predicts over 3000 targets for each arm, although some of these over-
lap (Supplementary Figure S1a). There are reportedly two distinct isomiRs of miR-324-3p, miR-324-3p.1 and 
-3p.239–41, which alter the predicted seed binding sequence and therefore also the predicted targets (Supplemen-
tary Figure S1b). However, most miRNA target prediction databases treat miR-324-3p.1 as the canonical form 
of miR-324-3p and hence this designation is used here. RNA-seq of RNA extracted from 13.5 month old male 
miR-324-null and WT mouse hippocampus and neocortex was undertaken in order to identify any predicted 
miR-324 targets or genes downstream of these in biological pathways that may be responsible for the observed 
epileptic phenotype (dataset freely available at GEO, accession GSE158337). The murine Mir324 locus is within 
a predicted 3′UTR transcript variant of Dvl2, antisense to the Acadvl locus, but no reads from either genotype 
mapped to the predicted variant of Dvl2 and reads that mapped to Acadvl did not differ between genotype 
(Supplementary Figure S2), confirming that hippocampal hyperexcitability identified was due to the removal 
of miR-324.
Principal component analysis (PCA) of the RNA-seq data showed variance corresponding to the different 
brain regions to be greater than the variance corresponding to the genotypes, due to the relatively low number of 
differentially expressed (DE) genes (Fig. 5a). However, when comparing all genes ranked by fold-change the two 
datasets were highly  correlative42 (Fig. 5b). The removal of the Mir324 locus resulted in 126 genes significantly DE 
(adjusted p value ≤ 0.05) in the hippocampus and 81 genes significantly DE in the neocortex. A total of 40 genes 
were DE in both tissues (Fig. 5c; list of shared DE genes shown in Supplementary Table S2). A number of the DE 
genes were also predicted targets of miR-324-5p or canonical miR-324-3p according to the TargetScan miRNA 
target prediction  algorithm4,33 (Fig. 5d). Of these predicted targets 6 were significantly upregulated (adjusted p 
value ≤ 0.05) in miR-324-null samples in both hippocampus and cortex (indicated in Supplementary Table S2). 
The expression of each of these genes was measured using qRT-PCR in the 13.5 month old male hippocampal 
samples and additionally in hippocampal samples from 7 month old male and female cohorts (Fig. 5e), and the 
expression Cd300lf, Sp6 and Suox was confirmed to be consistently increased in miR-324-null samples.
Disease Ontology enrichment  analysis43 showed that DE genes were significantly enriched for epilepsy syn-
drome in the hippocampus RNA-seq, but not in the neocortex (Fig. 6a). Therefore, related genes of interest 
(GOIs) were identified by filtering for epilepsy-associated genes in the Disease Ontology that were significantly 
DE in miR-324-null samples relative to WT controls, in either hippocampus or neocortex RNA-seq results 
(adjusted p value ≤ 0.05). Only 4 genes fitted these criteria, each of which was only significantly DE in the 
Figure 3.  Increased excitability in hippocampal slices obtained from female 5 month old miR-324-null mice. 
(a) IIDs were observed in some slices from miR-324-null mice. (b) A far higher proportion of miR-324-null 
hippocampal slices showed IIDs or a high number of spikes than WT slices (N = 16 slices obtained from 6 
mice per genotype). Any slice displaying at least one IID was classed as showing interictal activity, whilst slices 
showing no interictal activity but a high number of spikes were also grouped together. Slices were classed 
as showing high number of spikes if they had a greater number of spikes than the mean plus 2 SDs of spike 
number in the WT slices, for each KA concentration. For example, the mean plus 2 SDs of WT spikes at 150 
nM KA was 15.0, and therefore any slices at 150 nM with more than 15 spikes were classed as having a high 
number of spikes. The most prominent distinction between genotypes is seen at 150 and 200 nM KA, at both of 
which 37.5% of miR-324-null slices displayed interictal activity, whereas the vast majority of WT slices at these 
concentrations showed no abnormal activity.
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hippocampus (Table 1). These GOIs were measured using qRT-PCR in both the 13.5 month old (male) and the 7 
month old (male and female) hippocampal samples, with only Pnpo identified as significantly DE in all three data-
sets (Fig. 6b). Pnpo was consistently downregulated in miR-324-null samples and additionally was not predicted 
as a target of either miR-324 arm. Therefore, it was not considered to be a candidate novel miR-324 target gene. 
Figure 4.  Comparison of measures of excitability in electrophysiology data measured in hippocampal slices  
taken from 19 to 21 week old female miR-324-null and WT mice (N = 16 slices obtained from 6 mice per 
genotype). (a and b) Examples of traces following bath application of 150 nM KA that show large numbers of 
spikes (peaks more than 5SDs from the baseline) and IIDs, respectively (both measured in miR-324-null slices). 
The red dashed lines indicate 5 standard deviations above and below the baseline. (c and d) Electrophysiological 
traces of miR-324-null mice contained a significantly higher frequency of spikes and IIDs than WT control 
traces. The majority of slices obtained from WT mice showed no IIDs and therefore the frequency for these 
slices is zero. p Values were calculated using 2-way mixed ANOVAs of ranks, as the initial data was not normally 
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Dual‑luciferase assays reveal that Cd300lf and Suox are direct miR‑324‑5p targets. Although 
Cd300lf, Sp6 and Suox were validated to be significantly upregulated in miR-324-null mice at both 13.5 and 7 
months of age and are predicted targets of miR-324, the interactions between miR-324 and the 3′UTRs of these 
genes were not necessarily direct. In order to test this, 3′UTR-luciferase reporter assays were undertaken in 
murine C3H10T1/2. Both Cd300lf and Suox showed statistically significant reductions in activity in the presence 
of miR-324-5p but not miR-324-3p or a miRNA negative control mimic (miCon; Fig. 7a). Additionally, when 2 
nucleotides were mutated in the predicted binding sites of miR-324-5p in either of the Cd300lf and Suox 3′UTRs, 
the miR-324-5p-mediated downregulation was inhibited, strongly indicating that miR-324-5p binds the Cd300lf 
and Suox 3′UTRs in vitro and mediates repression of Cd300lf and Suox through these interactions (Fig. 7b). 
Western Blotting of SUOX and CD300lf from female hippocampal tissue aged 7 months revealed that the levels 
of both proteins increased in miR-324-null samples relative to WTs, although the increase in CD300lf levels did 
not achieve statistical significance at a 5% threshold (Fig. 7c).
Discussion
The electrophysiological analyses undertaken here illustrated a clear hippocampal hyperexcitability with an 
increase in epilepsy-associated events in mice lacking Mir324. However, the networks regulating oscillatory 
activity in the hippocampi of these mice are evidently not severely impaired, as no significant changes were 
observed in the area power, peak amplitude or peak frequency in slices obtained from miR-324-null animals. 
It is therefore unclear whether mice lacking Mir324 would develop any cognitive dysfunction relative to WT 
controls, and this should be a focus of future investigation. Additionally, it is unclear at what developmental 
timepoint the increased excitability emerges in the miR-324-null mice. In future studies it would be beneficial 
to undertake electrophysiology at earlier timepoints in these animals, in addition to developing a conditional 
KO model of miR-324, using for example the Fzd9-Cre mice, in which Cre recombinase expression is largely 
restricted the hippocampus and  cortex44,45. This would allow analysis of the effect of miR-324 KO only in these 
specific tissues and additionally when miR-324 expression is removed at specific developmental timepoints, 
reducing the risk of any compensatory mechanisms.
Investigation into which specific neuronal populations have been affected in miR-324 null mice is also essen-
tial in order to assess whether the increased excitability is universal throughout the hippocampus or whether 
there are subregional differences. Furthermore, despite no evidence of any obvious seizure activity upon obser-
vation of the transgenic mice in the home cage or in response to handling, no detailed studies of behaviour 
were undertaken as part of this study. Therefore in order to elucidate both the causes and consequences of the 
increased IIDs in miR-324-null mice, in vivo recordings in awake animals, combined with behavioural assess-
ments, are required.
The genetic cause of the increase in hyperexcitability is somewhat difficult to elucidate fully, but may stem 
from Pnpo and Suox, the two epilepsy-associated genes found to be significantly DE in the hippocampus, both 
in RNA-seq and qRT-PCR. Pnpo expression was decreased in hippocampal miR-324-null samples. In humans, 
mutant PNPO results in a specific form of epilepsy known as pyridoxal-phosphate dependent epilepsy (PPDE). 
This presents due to the inability of affected individuals to produce sufficient levels of pyridoxal-5′-phosphate 
(P5P), a key cofactor for many neurotransmitter biosynthesis  reactions46,47. Patients affected by PPDE often pre-
sent with neonatal epileptic encephalopathy, although some cases of later-onset epilepsy can also be effectively 
treated with P5P. This suggests that there may be a far broader spectrum of phenotypes for individuals lacking 
PNPO than is currently suggested in the  literature48,49. It is, therefore, conceivable that the decreased expression 
of Pnpo in miR-324-null mice could play a role in the generation of increased epileptic events identified here.
Suox was also identified to be DE in miR-324-null mice, in addition to being a novel direct target of miR-
324-5p in vitro. In humans, SUOX is associated with isolated sulfite oxidase deficiency (ISOD), a disorder caused 
by lack of functional SUOX. ISOD, like PPDE, is associated with increased epileptic events in  patients50, although 
the relative gene expression of SUOX in ISOD is decreased, rather than the increased Suox expression identi-
fied in miR-324-null mice. It is possible that an excess of murine SUOX results in a phenotype similar to that 
of human SUOX deficiency, although there are no studies in the literature discussing this, and so exactly what 
effect an increase in Suox expression may have is currently unknown.
The second novel miR-324-5p target identified in this study, Cd300lf, has no direct link to epilepsy in the 
literature. However, it has previously been reported that in the THP-1 human cell line, treatment with CD300LF 
results in reduced levels of MMP-951, a matrix metalloproteinase (MMP) which, along with the 22 other human 
MMPs, is key to the maintenance of extracellular matrix across many biological  processes52,53. These include 
maintenance of the blood–brain barrier and homeostatic regulation of synaptic excitability, both of which have 
previously been demonstrated to be regulated in part by the activity of MMP-954–57. Thus, the lack of Cd300lf 
repression in miR-324-null mice may result in reduced levels of MMP-9, therefore contributing to the abnor-
mal neurological activity seen in vitro in hippocampal slices from miR-324-null mice. However, any CD300lf-
mediated Mmp9 repression would necessarily be subtle, considering we identified no significant change at a 
transcriptomic level. Further investigation is therefore required to identify whether this dysregulation of the 
CD300lf-MMP-9 pathway can affect MMP-9 levels to any biologically meaningful extent.
In addition to epilepsy, other neurological conditions identified in the Disease Ontology analysis included 
bipolar disorder, attention deficit hyperactivity disorder (ADHD) and schizophrenia. Interestingly, all these con-
ditions have also been shown to be associated with cortical  hyperexcitability58–61. We, therefore, cannot exclude 
the possibility that the increase in hippocampal excitability reported here could also point to a role of miR-324 
in other neurological conditions.
Previously, downregulation of miR-324 using an antagomir has been associated with decreased epilep-
tic  activity30, compared to the increase in IIDs and spikes shown here. However, there were several notable 
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differences between the two studies; Tiwari et al. (2019) used an injectable miR-324-5p antagomir to produce a 
transient miR-324-5p downregulation, and tested the effect of this in mouse models of epilepsy where pilocarpine 
had been used to induce status epilepticus. It is therefore possible that different phenotypes are seen because 
miR-324-5p was only transiently downregulated. Additionally, pilocarpine treatment in mice has been shown to 
induce changes in a large number of  genes62,63, which may also play a role in the difference between the results 
identified in our study and those identified by Tiwari et al. Interestingly, the downregulation of Kv4.2 by miR-
324-5p observed by Gross et al. was observed only during or shortly after seizure activity and therefore future 
studies should explore whether miR-324 targets different genes and therefore produces different effects in the 
hippocampus during status epilepticus compared to under non-seizure circumstances.
Although the novel miR-324 targets identified and validated in this study appear to respond similarly to miR-
324 in both murine tissue and the C3H10T1/2 cell line, it is possible that some targets of miR-324 were unable 
to be identified by the methodology we used. For example, Gpc1 and App, the latter of which is one the most 
confidently predicted miR-324-5p  targets4,33, were previously identified as direct targets of miR-324-5p using 
both transcriptomic and proteomic techniques in C3H10T1/2  cells64. However, in our RNA-seq experiment 
there is no significant increase in the expression of either gene. Another reported miR-324-5p target, Kv4.2, was 
identified using luciferase assays and proteomic analyses, but the authors reported that no changes in mRNA 
levels were  identified29. We also identified no significant changes to Kv4.2 mRNA levels between miR-324-null 
and WT mice using RNA-seq. All three of these genes have been implicated in neurological activity; Gpc1 in 
relation to the developmental regulation of brain  size65, App in the amyloidogenesis  pathway32 and Kv4.2 in the 
regulation of seizure activity and  excitability36,37. Given the close relationship of these genes to the phenotypes 
observed in miR-324-null mice, all of these genes may well be also be direct miR-324-5p targets, and the fact 
that they were not identified in this study could be attributed to the lack of in-depth proteomic analyses in addi-
tion to the differences in models used. However, considering that the vast majority of protein level alteration 
can be attributed to a change in the amount of corresponding  mRNA66, it is reasonable to assume that the target 
identification analysis undertaken in this study should have detected most direct miR-324 target genes that were 
expressed at a reasonable level in the murine hippocampus and neocortex. It should also be considered that in 
the case of Gpc1 and App, Mir324 was removed rather than overexpressed, and therefore the possibility remains 
that although these genes fulfil all in silico miR-324-5p target requirements, very little regulation by miR-324-5p 
occurs in vivo under physiological miR-324-5p levels.
The greatest limitations of the study presented here are the differences in age and sex between the mice used 
for each experiment. Although age and sex are always controlled for direct comparisons, there is a risk that the 
conclusions of each experiment do not necessarily hold for all timepoints, considering that there are notable 
increases in CA3 neuronal activity with  age67,68 and many epilepsies are widely regarded as being more prevalent 
in either males or  females69. Additionally it is possible that the expression of Mir324 is altered with age or sex; 
many key miRNAs are upregulated in the ageing  brain70, including miR-34a71, which also shows differential 
expression by  sex72. The qRT-PCR validation of putative miR-324 target genes shows that, at least at a tran-
scriptomic level, the novel miR-324 target genes identified in this study respond similarly to lack of miR-324 in 
samples from 13.5 month males, 7 month old females and 7 month old males, thus minimising these limitations, 
but not eliminating them entirely.
In summary, this study presents the first global miR-324-null mice and shows that hippocampal slices from 
these animals show increased excitability with an increased IID frequency relative to WT controls. Two epilepsy-
associated genes are identified to be DE in the hippocampus and neocortex in mice lacking Mir324; Suox and 
Pnpo. Additionally, Suox is shown to be a direct target of miR-324-5p in vitro, as is Cd300lf, a gene indirectly 
associated with neurological function through MMPs. The abnormal hippocampal excitability seen in slices from 
miR-324-null mice may result from the altered expression of one or multiple of these genes. Further investiga-
tion into the downstream effects of Mir324 removal may reveal novel pathways involved in ISOD and PPDE and 
therefore also may identify novel pharmaceutical targets for treating these conditions.
Figure 5.  Initial analysis of RNA-seq of hippocampus and neocortex in 13.5 month old male miR-324-null 
and WT mice. (a and b) PCA analysis does not show as strong a segregation of samples by genotype as it does 
by tissue, although the results of hippocampus and neocortex RNA-seq experiments are well correlated using 
RRHO (sample permutation p value < 0.001). (c) Only 40 of the genes found to be DE in miR-324-null samples 
relative to WT controls were found to be DE in both tissues. (d) Volcano plots for hippocampus and neocortex 
tissue showing the fold-change, adjusted p value of each gene in addition to whether it is a predicted target of 
either arm of miR-324 according to the TargetScan  algorithm4,33. Genes significantly increased in expression 
in miR-324-null samples are shown in blue, genes significantly decreased in expression are shown in green 
and genes showing no significant changes (p value > 0.05) are coloured grey. Genes found to be significantly 
upregulated in miR-324-null hippocampus and neocortex, in addition to being a miR-324 target, are labelled. 
(e) Of the genes that were predicted targets of miR-324 and significantly upregulated in both the hippocampus 
and neocortex RNA-seq, only Cd300lf and Suox were significantly DE in all cohorts by qRT-PCR analysis. Sp6 
was also highly upregulated, but it was detected in none of the WT samples in any cohort and so statistical 
significance could not be calculated. *, ** and *** indicate p values ≤ 0.05, 0.01 and 0.001 respectively, using two-
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Methods
miR‑324‑null mouse models. All animal experiments were performed under licenses granted from the 
Home Office (United Kingdom) in accordance with the guidelines and regulations for the care and use of labo-
ratory animals outlined by the Animals (Scientific Procedures) Act 1986 according to Directive 2010/63/EU of 
the European Parliament, and conducted according to protocols approved by the Animal Ethics Committee of 
Newcastle University and the Home Office, United Kingdom. Breeding and subsequent phenotyping was per-
formed under licence P8A8B649A. All animal experiments were performed in compliance with the ARRIVE 
Figure 6.  Relation of RNA-seq results to epilepsy. (a) Epilepsy syndrome was significantly enriched in the 
hippocampus RNA-seq, but not in the neocortex experiment (p values = 0.03 and 0.74 respectively), using 
terms and gene associations from the Disease Ontology. The significance of each Disease Ontology term 
was established using a Kolmogorov–Smirnov test. The dotted line on each plot shows where the cut-off for 
significance at a 5% level is found. (b) qRT-PCR quantification of the expression of epilepsy-associated genes 
was undertaken in the hippocampus tissue of the 13.5 month old male RNA-seq cohort and in 7 month old 
male and female hippocampal validation cohorts. * and ** indicate p values ≤ 0.05 and 0.01 respectively, using 
two-sided Student’s t-tests to assess statistical significance. Only Pnpo is significantly DE in all three cohorts.
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guidelines (http:// www. nc3rs. org. uk/ page. asp? id= 1357). CRISPR/Cas9 guide RNAs (crRNAs) were designed 
using  CHOPCHOP73,74. crRNAs linked with TRACR (sgRNA) were amplified by PCR with a pLKO vector 
(Addgene_52628) as template, with a T7 TRACR R primer (5′-AAA AGC ACC GAC TCG GTG CC-3′) in combi-
nation with a 5´ PCR primer that included a T7 sequence and specific crRNA (shown in bold; 5′-atgcatTTA ATA 
CGA CTC ACT ATA gGGAGG CTT CCG ACT TTG TAA AGGTT TTA GAG CTA GAAAT-3′; 5′-atgcatTTA ATA 
CGA CTC ACT ATA gGGAGC TGG AGA CCC ACT GCC CCGTT TTA GAG CTA GAAAT-3′). This was converted 
to RNA using the MEGAshortscript T7 kit (Thermo Fisher Scientific). sgRNAs (50 ng/ml each) were mixed with 
recombinant Cas9 (ToolGen, CamBioScience Limited) and injected into the cytoplasm of donor mouse zygotes 
and transferred into recipient foster mothers, all essentially as previously  described75–77. This resulted in a 133 
bp deletion at the Mir324 locus. The mixed C57BL/6 and CBA/ca  F0 mice were backcrossed onto C57BL/6 J and 
heterozygous animals crossed three times to eventually generate WT and miR-324-null lines. Genotype was con-
firmed by ear-notch PCR and Sanger sequencing (Forward primer: 5′-GTG CTG ATC TAC TCC TCC AACC-3′; 
reverse primer: 5′-AAA TTC ACA ACT TTG GGG TGAT-3′). All experimentation after breeding and phenotyping 
was performed under licence P6EE54A50.
miR‑324‑5p in situ hybridisation. Brains were obtained from 2 WT male mice (aged 4 months), fixed in 
10% neutral-buffered formalin (w/v) and embedded in paraffin. A Microm HM355S Rotary Microtome (Thermo 
Fisher Scientific) was used to cut 5 µm horizontal sections at approximately − 5 mm along the DV axis relative 
to the  bregma78,79. The levels of miR-324-5p (custom designed probe), U6 (miRNAscope positive control) and 
a scrambled probe (miRNAscope negative control) were assessed in sections taken from each WT mouse using 
the miRNAscope HD Assay  Red80 (Advanced Cell Diagnostics) following the manufacturer’s standard protocol. 
Samples were counterstained with Mayer’s Hematoxylin Solution (Sigma-Aldrich) and subsequently imaged 
using an Axiovert 200 Inverted Microscope (Zeiss).
Hippocampus slice preparation. Female miR-324 KO and WT mice (aged 5 months) were anaesthetised 
by inhalation of 100% isoflurane, before intramuscular injections with ketamine (≥ 100 mg/kg) and xylazine 
(≥ 10 mg/kg). After the pedal withdrawal reflex had ceased, the mice underwent a transcardial perfusion with 
30 ml of sucrose artificial cerebrospinal fluid (aCSF), via injection into the left ventricle. The sucrose aCSF was 
composed of the following: 204.5 mM sucrose, 3.0 mM KCl, 1.25 mM  NaH2PO4, 2.0 mM  MgSO4, 2.0 mM 
 CaCl2·2H2O, 10.0 mM of D-glucose and 24.0 mM  NaHCO3 (all from Sigma-Aldrich). The brain was excised and 
450 µm horizontal hippocampal sections were cut using a vibratome (Model 5100 mz, Campden Instruments). 
The overlying cortex was trimmed from around the hippocampus, before being placed in a holding chamber at 
room temperature at an interface between carbogen gas and aCSF (with sucrose replaced by 126 mM NaCl) for 1 
h. In order to avoid any confounding issues due to dorsal–ventral (DV) differences within the  hippocampus81–83 
we used only slices from the central portion of the hippocampus (between − 3.24 mm and − 5.04 mm along the 
DV axis relative to the  bregma78,79).
Electrophysiology data acquisition. Extracellular recording electrodes with resistances of 2–5 mΩ were 
produced from glass capillary tubes (Thin Wall Borosilicate with filament; Harvard Apparatus) using a micro-
pipette puller (Model P-97, Sutter Instrument), before being filled with aCSF using a microfil syringe. Once 
the hippocampal slices had been in the holding chamber for approximately 40 min, they were transferred to a 
recording chamber that was kept at 30–32 °C, and through which 100 ml of aCSF was continuously recycled. 
The slices were left to acclimatise for 15 min, before LFPs were measured from the stratum radiatum layer of the 
CA3 region. The signal was amplified 10× by an AI-2010 differential amplifier (Axon Instruments) and back-
ground noise was minimised using a 50 Hz HumBug noise eliminator (Quest Scientific). Neurolog external 
filters (Digitimer Ltd.) were used to filter the signal at 1 Hz high-pass and 300 Hz low-pass, with a sampling rate 
of 5000 Hz, and an ITC-18 (NPI Electronic) was used to convert the analogue signal to digital. Spontaneous LFP 
activity was recorded for 30 min, before bath application of 50 nM KA (Sigma-Aldrich). The resulting activity 
was recorded for a further 30 min, before the concentration of KA was increased every 30 min to 100 nM, 150 
nM, 200 nM, 400 nM, 600 nM, 800 nM and 1 µM. Trace recordings were performed using Axograph X v1.7.2 
(Axograph Scientific).
Electrophysiology data analysis. Power spectra were generated from the last minute at each KA concen-
tration, using Axograph. The peak frequency, peak amplitude and power area (from 15 to 48 Hz) of oscillations 
Table 1.  Genes found to be DE (adjusted p value ≤ 0.05) in either the hippocampus or neocortex RNA-seq 
experiments that are associated with epilepsy according to the Disease  Ontology43.
Gene
Hippocampus RNA-seq Neocortex RNA-seq
logFC Adjusted p value logFC Adjusted p value
Pnpo − 0.523 3.20 ×  10–5 − 0.253 0.248
Scn5a 1.21 0.00240 0.0309 0.989
Gria1 0.295 0.0282 0.0678 0.850
Gad1 0.270 0.0466 0.186 0.315
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Figure 7.  Identification of novel miR-324-5p targets using 3′UTR luciferase assays. (a) C3H10T1/2 murine cells were 
transfected with 3′UTR-pmiRGLO constructs and subsequently also with either a negative control miRNA mimic (miCon) 
or a mimic of miR-324-5p or miR-324-3p. Luciferase activity was measured after cells were incubated at 37 °C for 24 h. 
Relative luciferase activity was calculated as a ratio of renilla activity, an internal transfection control of pmiRGLO, and 
values were plotted as a percentage of mean miCon luciferase activity for each construct. Suox and Cd300lf, but not Sp6, were 
identified as direct miR-324-5p targets in vitro. (b) When 2nts of the miR-324 binding sites of the Cd300lf and Suox 3′UTRs 
were mutated, shown as Cd300lf(mut) and Suox(mut), the miR-324-5p-mediated repression was inhibited in both cases. The 
predicted miR-324-5p binding sites of each 3′UTR are shown above the panel corresponding to that 3′UTR, with mutations 
highlighted in black. For panels a and b, the means of at least 3 independent experiments were used to test statistical 
significance in two-tailed Student’s t-tests. A negative control was included for each independent experiment (pmiRGLO) in 
addition to miCon and, after miR-324 targets were identified, one of these was used as a positive control for each independent 
experiment. (c) Western Blotting was used to confirm that the changes to the quantity of target gene mRNAs affected levels 
of the corresponding proteins in female hippocampal tissue aged 7 months. SUOX levels were significantly increased in miR-
324-null samples relative to WT controls and although levels of CD300lf were not statistically significantly increased at a 5% 
level (p value = 0.077), there was a trend towards increased expression in miR-324-null samples. SUOX and CD300lf band 
intensities were normalised against GAPDH. In all panels, ** indicates p values ≤ 0.01.
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from each trace were measured and compared between genotypes. For some slices at high KA concentrations, 
an additional faster frequency was observed in the power spectra in addition to the gamma peak. For the pur-
poses of assessing differences in gamma band activity, only the lower gamma-frequency peak was measured. At 
each KA concentration, only slices showing clear gamma-frequency oscillations were included for analysis. The 
standard deviation (SD) of the amplitude for the final minute of each trace was also measured and Axograph was 
used to detect peaks in the LFP at least 5 SDs from the baseline of that trace. These were defined as “spikes” as 
they occurred during clear gamma activity and were not full IIDs. A proportion of events were identified manu-
ally as IIDs, which are established biomarkers of epilepsy and which result from imbalance in the excitation and 
inhibition in neural  networks84–86. Additionally, in order to summarise the data, slices that showed any IIDs 
were classed as displaying interictal activity, and those showing no IIDs but a higher number of spikes than the 
mean plus 2 SDs of WT slice spikes at each KA concentration were classed as showing a high number of spikes. 
The remaining slices were classed as showing no abnormal activity in response to KA. Measurements were taken 
from 6 miR-324 KO mice and 6 WT mice, and multiple slices were taken from each of these mice (details shown 
in Supplementary Table S1), giving an overall sample size of 32, consisting of 16 WT slices and 16 KO slices. Each 
slice was treated as one sample, due to the considerable variability in the power of oscillations. For each metric, 
two-way mixed ANOVA tests or variants were used to assess statistical significance of the effect of genotype and 
KA concentration. Where the data was not normally distributed, it was either  log10 transformed or a two-way 
mixed ANOVA of ranks was used.
RNA extraction from murine tissue and cells. RNA was extracted from murine tissue using the mir-
Vana miRNA Isolation Kit (Thermo Fisher Scientific), following the manufacturer’s protocol to isolate total 
RNA. For RNA extraction from C3H10T1/2 cells, QIAzol Lysis Reagent (QIAGEN Ltd.) was used, following 
standard protocols. A NanoDrop™ 1000 Spectrophotometer (Thermo Fisher Scientific) was used to measure the 
RNA concentration and purity.
RNA sequencing and analysis. Prior to RNA-seq, RNA samples were purified using the DNA-free DNA 
Removal Kit (Invitrogen) to remove any DNA contamination. The sequencing library was prepared using the 
Illumina TruSeq Stranded mRNA sample preparation kit following the manufacturer’s protocol and subsequent 
sequencing was performed on an Illumina NextSeq 500.  Kallisto87 was used for pseudo-alignment and quan-
tification, against the mouse GRCm38 (release 92)  transcriptome88. Mapped transcripts were converted to a 
gene level using  Tximport89 and  DESeq290 was used to calculate p values and  log2 fold-changes (logFC), using 
the Benjamini–Hochberg method to adjust for multiple testing. Integrated Genomics  Viewer91,92 was used to 
produce sashimi plots for each tissue, in order to analyse whether any splicing variation occurred upon removal 
of Mir324. Rank-rank hypogeometric overlap (RRHO)93 of the RNA-seq results from the hippocampus and 
neocortex was carried out using the RRHO package in  R42, with the logFC of each gene used as the comparison 
statistic. Sample permutation p values were also computed using the RRHO package, calculated using the sum 
of the signal from genes sharing similar logFC values in both hippocampus and neocortex RNA-seq results. 
Putative miR-324 target genes were identified by filtering initial RNA-seq results for genes that were upregulated 
in miR-324-null mice in both hippocampus and neocortex tissue and that were predicted to be targets of either 
miR-324-5p or miR-324-3p by the TargetScan 7.2  algorithm4,33. Other GOIs from the RNA-seq results were 
identified by utilising the Disease  Ontology43, using the term “epilepsy syndrome” to filter for relevant genes, 
with murine genes first converted to their human homologues using the BiomaRt R  package94. The Disease 
Ontology was also used to test to test for enrichment in specific diseases, using a Kolmogorov–Smirnov test for 
significant enrichment with the GOseq R  package95. For this, DE genes were defined as those with adjusted p 
values ≤ 0.05.
Reverse transcription and quantitative PCR. Complementary DNA (cDNA) was reverse transcribed 
from total RNA using M-MLV Reverse Transcriptase (Thermo Fisher Scientific), following the manufacturer’s 
protocol for each GOI. cDNA was then quantified using TaqMan Fast Advanced Master Mix (Thermo Fisher 
Scientific). Reverse transcription of Mir324 and the housekeeping gene U6 were undertaken essentially as previ-
ously  described64. GOI mRNA levels were quantified using a Quant Studio 3 (Thermo Fisher Scientific), using 
specific primers and Universal Probe Library (UPL; Roche Molecular Systems) probes (Supplementary Table S3) 
to measure the amplification of individual GOIs. Each sample was heated to 95 °C for 20 s, before undergoing 50 
cycles of heating to 95 °C for 1 s and 60 °C for 20 s. The ΔCt method of normalisation was used to account for 
any differences between the samples, using U6 to normalise Mir324 levels and the housekeeping gene Ndufa2 to 
normalise every other gene tested. Therefore, the normalised Cts (cycle thresholds) were calculated as follows: 
2
−(CtGOI−CtNormaliser ) . The normalised Cts measured in miR-324 KO samples were compared against those meas-
ured in WT samples to assess whether there was any statistically significant difference for each GOI.
Construction of 3′ untranslated region luciferase reporter plasmids. Fragments of the 3′UTR 
regions of putative miR-324 targets were amplified from cDNA, which was reverse transcribed from RNA 
extracted from C3H10T1/2 cells. PCR primers (Supplementary Table S4) were designed for In-Fusion HD clon-
ing (Takara Bio Inc.) into the pmiRGLO luciferase reporter plasmid (Promega Corporation), which was digested 
with XhoI restriction endonuclease (New England Biolabs (UK) Ltd.). All predicted miR-324 binding sites were 
included in the amplified regions. Mutant Suox 3′UTR was synthesised as a gBlock (Integrated DNA Technolo-
gies), again designed for In-Fusion HD cloning. Mutant Cd300lf (at both predicted miR-324-5p binding sites) 
was produced by site-directed mutagenesis of the pmiRGLO-Cd300lf plasmid, using QuikChange Lightning 
(Agilent Technologies; mutagenesis sites shown in lower case; site 1 forward primer: 5′-AGG CAG GCT GCT 
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TCAGGcAgGCT GTG TAA ATC GTATC-3′; site 1 reverse primer: 5′-GAT ACG ATT TAC ACAGCcTgCCT GAA 
GCA GCC TGCCT-3′; site 2 forward primer: 5′-AGC AGA AGG TGG AGGcAgGCA GAA GGA GTC AGG-3′; site 
2 reverse primer: 5′-CCT GAC TCC TTC TGCcTgCCT CCA CCT TCT GCT-3′). Both mutant constructs con-
tained mutations of 2 nucleotides within the predicted miR-324 binding sites. For all 3′UTR constructs except 
mutant Cd300lf, In-Fusion HD cloning was used, following the manufacturer’s protocol. All constructs under-
went confirmation by Sanger sequencing (Source BioScience).
Cell culture and dual‑luciferase assay. Murine C3H10T1/2 cells were cultured at 37 °C and 5% (v/v) 
 CO2 in Minimal Essential Medium (MEM), supplemented with 2 mM L-glutamine, 10% foetal bovine serum, 
100 μg/ml streptomycin and 100 IU/ml penicillin, using vented  T75cm2 flasks as previously  described64. Cells 
were seeded onto 96 well plates at 5000 cells/well, before being incubated at 37 °C for 18 h. Subsequently, cells 
were transfected with the pmiRGLO-3′UTR constructs using FuGENE HD Transfection Reagent (Promega 
Corporation) following the manufacturer’s protocol. These cells were incubated at 37 °C for 4 h, media was 
aspirated, and the cells were transfected with miCon2 (Control miRNA Mimic (miCon)) or miR-324-5p or 
miR-324-3p mimics at a final concentration of 50 nM using DharmaFECT 1 (all Horizon Discovery) transfec-
tion reagent. The cells were incubated at 37 °C for 24 h after which the media was aspirated, cells washed with 
phosphate-buffered saline (PBS) and lysed using 30 µl of Passive Lysis Buffer (Promega Corporation). Luciferase 
level of each well was determined relative to an internal Renilla control using a GloMax-Multi Detection System 
(Promega Corporation) and reagents from the Dual-Luciferase Reporter Assay System (Promega). For each 
pmiRGLO-3′UTR construct, 6 technical replicates were measured for each of miR-324-5p, miR-324-3p and 
miCon. The mean values from at least 3 independent experiments were used to calculate statistical significance. 
A negative control was included in every independent experiment and, after miR-324 targets were identified, one 
of these was used as a positive control for each subsequent experiment.
Protein extraction and Western Blotting. Murine hippocampal samples were ground into a fine pow-
der on dry ice, before each sample was resuspended in 150 µl of a 1% (v/v) TritonX lysis buffer. Samples were 
subsequently kept on ice for 25 min, before undergoing centrifugation at 13,000×g for 10 min, cooled to 4 °C. 
The supernatant was quantified using a Bradford Assay and 10 µg was heated to 105 °C for 5 min to denature 
the protein, before being resolved on a 10% (w/v) SDS-PAGE gel and transferred to a PVDF membrane. The 
membrane was incubated overnight at 4 °C with the following primary antibodies: SUOX (Invitrogen, catalogue 
number PA5-21705; used at 1:200 dilution), CD300f./LMIR3 (R&D Systems, catalogue number AF2788; used at 
0.2 µg/ml), GAPDH (Sigma-Aldrich, product number MAB374; used at 1:40,000 dilution). Band visualisation 
was undertaken using HRP-conjugated secondary antibodies (Dako, Agilent Technologies, product number 
P0448; used at 1:1000 dilution) and Immobilon Western Chemiluminescent HRP Substrate (Merck Millipore 
UK Ltd.) and subsequent quantification was performed using  Fiji96.
Statistical analysis. Where data was of a normal distribution (tested using the Shapiro–Wilk test for nor-
mality), statistical significance was assessed using Student’s two-tailed t-test for single comparisons or analysis of 
variance (ANOVA) for testing the effects of multiple variables on a continuous variable output; the test used for 
each comparison is indicated in the corresponding figure legend. Where data was non-parametric, Mann–Whit-
ney U tests were used to assess significance of single comparisons and either  log10 transformed two-way ANOVA 
tests or ANOVA of rank tests were used for the effects of multiple comparisons. Tukey’s HSD tests were used for 
post-hoc testing. All data analysis and statistical calculations were performed using R version 3.6.297. Relevant R 
packages used for statistical analysis are cited.
Data availability
RNA-seq data is freely available at GEO (accession GSE158337) and all other datasets are available from the 
corresponding author on reasonable request.
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